(Q45141158)

10 December 2017

title

Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry (English)

1 reference

10 December 2017

1 reference

Laura Chow

1

1 reference

10 December 2017

Raymond Lai

2

1 reference

10 December 2017

Laith Dabbagh

3

1 reference

10 December 2017

Andrew Belch

4

1 reference

10 December 2017

James D Young

5

1 reference

10 December 2017

Carol E Cass

6

1 reference

10 December 2017

John R Mackey

7

1 reference

10 December 2017

publication date

1 April 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

18

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

558-564

1 reference

describes a project that uses

10 December 2017

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800323

0 references

cites work

Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Gemcitabine for relapsed or resistant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Gemcitabine in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Nucleoside transporters: molecular biology and implications for therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Nucleoside transport and its significance for anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

PKC regulation of the human equilibrative nucleoside transporter, hENT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

Cytosine arabinoside transport by human leukaemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800323

7 January 2021

10.1038/MODPATHOL.3800323

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1052110078

0 references

1 reference